These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 22338222

  • 1. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX, Sun N, Ma GY, Wang MM, Sa D, Shi C, Wu JL, Lin X, Xiao Y, Qian YH, Jiang Y, Xie J, Ji YY, Guan HX.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
    [Abstract] [Full Text] [Related]

  • 2. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ, Müller M, Kollaritsch H, Pinl F, Schmitt B, Zeitlinger M, Loew-Baselli A, Kreil TR, Kistner O, Portsmouth D, Fritsch S, Maritsch F, Aichinger G, Pavlova BG, Barrett PN.
    Vaccine; 2012 Jun 22; 30(30):4543-51. PubMed ID: 22475864
    [Abstract] [Full Text] [Related]

  • 3. [Analysis of hemagglutination inhibition antibody level in patients with influenza A H1N1].
    Shen HH, Hou J, Zhao M, Xu J, Bai BK, Zhao J, Hu Y, Mao PY, Li BA, Mao YL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug 22; 26(4):270-2. PubMed ID: 23189841
    [Abstract] [Full Text] [Related]

  • 4. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA, Smolonogina TA, Donina SA, Rudenko LG.
    BMC Res Notes; 2015 Apr 10; 8():136. PubMed ID: 25889924
    [Abstract] [Full Text] [Related]

  • 5. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E, Boschini A, Amendola A, Poletti R, Anselmi G, Begnini M, Ranghiero A, Cecconi G, Zanetti AR.
    Vaccine; 2011 Nov 15; 29(49):9209-13. PubMed ID: 21974995
    [Abstract] [Full Text] [Related]

  • 6. [Herd immunity against new influenza A (H1N1) in pre-vaccinated residents aged over 5 years in Beijing].
    Lu L, Liu DL, Zhang TG, Chen M, Zhang ZJ, Wang XL, Yang Z, Pang XH, Deng Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun 15; 33(6):403-5. PubMed ID: 20979808
    [Abstract] [Full Text] [Related]

  • 7. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.
    Yen TY, Jou ST, Yang YL, Chang HH, Lu MY, Lin DT, Lin KH, Huang LM, Chang LY.
    Pediatr Blood Cancer; 2011 Dec 15; 57(7):1154-8. PubMed ID: 21425448
    [Abstract] [Full Text] [Related]

  • 8. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT, Guo CY, Tsai MS, Cheng YY, Lin MT, Chen CH, Shen D, Wang JR, Sung JM.
    Vaccine; 2012 Jul 13; 30(33):5009-18. PubMed ID: 22658967
    [Abstract] [Full Text] [Related]

  • 9. Low seroprotection against preseasonal influenza local strains in children might predict the upcoming epidemic influenza strains.
    Su WJ, Shao PL, Liu MT, Liu DP, Huang KC, Chang LY, Lu CY, Wang JR, Shih SR, Huang DT, Chi H, Huang LM.
    Clin Infect Dis; 2010 Jul 15; 51(2):171-6. PubMed ID: 20528478
    [Abstract] [Full Text] [Related]

  • 10. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
    Lemaitre M, Leruez-Ville M, De Lamballerie XN, Salez N, Garrone P, Fluckiger AC, Klatzmann D, Carrat F.
    Clin Microbiol Infect; 2011 May 15; 17(5):732-7. PubMed ID: 20731679
    [Abstract] [Full Text] [Related]

  • 11. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
    Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM.
    Ann Rheum Dis; 2011 Dec 15; 70(12):2144-7. PubMed ID: 21859696
    [Abstract] [Full Text] [Related]

  • 12. Serological survey of 2009 H1N1 influenza in residents of Beijing, China.
    Deng Y, Pang XH, Yang P, Shi WX, Tian LL, Liu BW, Li S, Cui SJ, Li Y, Lu GL, Zhang L, Zhang X, Liu B, Seale H, Huang F, Wang QY.
    Epidemiol Infect; 2011 Jan 15; 139(1):52-8. PubMed ID: 20854713
    [Abstract] [Full Text] [Related]

  • 13. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H, Jeganathan S, Smith DE, Robertson P, Barnes T, Furner V.
    HIV Med; 2012 Jul 15; 13(6):352-7. PubMed ID: 22296264
    [Abstract] [Full Text] [Related]

  • 14. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Gilca V, De Serres G, Hamelin ME, Boivin G, Ouakki M, Boulianne N, Sauvageau C, Dionne M, Gilca R, Skowronski D.
    Vaccine; 2011 Dec 09; 30(1):35-41. PubMed ID: 22063386
    [Abstract] [Full Text] [Related]

  • 15. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 09; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.
    Zhan Y, Yang Z, Li L, Ye D, Wu H, Fu R, Zhao S, Wang Y, Zhou R, Chen R.
    Jpn J Infect Dis; 2011 Jul 09; 64(3):190-4. PubMed ID: 21617301
    [Abstract] [Full Text] [Related]

  • 17. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC, Choy PW, Lee WY, Wong AH, Ng KC, Lim W.
    J Med Virol; 2010 Nov 09; 82(11):1809-15. PubMed ID: 20872705
    [Abstract] [Full Text] [Related]

  • 18. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J, Salez N, Ninove L, Kieffer A, Zandotti C, Seston M, Lina B, Nougairede A, Charrel R, Flahault A, de Lamballerie X.
    Clin Microbiol Infect; 2012 Feb 09; 18(2):177-83. PubMed ID: 21635661
    [Abstract] [Full Text] [Related]

  • 19. Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine.
    Chao DY, Cheng KF, Hsieh YH, Li TC, Wu TN, Chen CY, Tsai CA, Chen JH, Chiu HT, Lu JJ, Su MC, Liao YH, CIDER.
    Vaccine; 2011 Jan 17; 29(4):617-23. PubMed ID: 21095255
    [Abstract] [Full Text] [Related]

  • 20. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
    Uno S, Kimachi K, Matsuo F, Miyazaki K, Oohama A, Kei J, Nishimura T, Odoh K, Kino Y.
    Microbiol Immunol; 2012 Dec 17; 56(12):810-6. PubMed ID: 23009167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.